Citadel Advisors
CLPT icon

Citadel Advisors’s ClearPoint Neuro CLPT Stock Holding History

Citadel Advisors’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$382K Sell
42,000
-36,200
-46% -$457K ﹤0.01% 9912
2025
Q4 		$1.07M Sell
78,200
-5,600
-7% -$104K ﹤0.01% 7247
2025
Q3 		$1.83M Buy
83,800
+47,800
+133% +$563K ﹤0.01% 6256
2025
Q2 		$430K Buy
36,000
+5,900
+20% +$74.3K ﹤0.01% 8983
2025
Q1 		$358K Buy
30,100
+13,000
+76% +$202K ﹤0.01% 9198
2024
Q4 		$263K Sell
17,100
-9,000
-34% -$117K ﹤0.01% 9924
2024
Q3 		$293K Buy
26,100
+22,700
+668% +$217K ﹤0.01% 9388
2024
Q2 		$18.3K Sell
3,400
-1,800
-35% -$10.4K ﹤0.01% 12718
2024
Q1 		$35.4K Buy
5,200
+3,100
+148% +$21.7K ﹤0.01% 12517
2023
Q4 		$14.3K Sell
2,100
-2,400
-53% -$13.6K ﹤0.01% 12886
2023
Q3 		$22.5K Sell
4,500
-12,800
-74% -$76.2K ﹤0.01% 12532
2023
Q2 		$125K Sell
17,300
-14,100
-45% -$120K ﹤0.01% 10586
2023
Q1 		$265K Sell
31,400
-6,700
-18% -$58.7K ﹤0.01% 9632
2022
Q4 		$323K Sell
38,100
-97,400
-72% -$923K ﹤0.01% 9154
2022
Q3 		$1.4M Buy
135,500
+120,400
+797% +$1.59M ﹤0.01% 6286
2022
Q2 		$197K Sell
15,100
-2,100
-12% -$21.5K ﹤0.01% 10710
2022
Q1 		$179K Sell
17,200
-34,400
-67% -$313K ﹤0.01% 11655
2021
Q4 		$579K Sell
51,600
-9,500
-16% -$142K ﹤0.01% 9339
2021
Q3 		$1.08M Buy
61,100
+4,100
+7% +$76.9K ﹤0.01% 7937
2021
Q2 		$1.09M Buy
+57,000
New +$1.1M ﹤0.01% 8153

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Citadel Advisors's CLPT Position: Q1 2026 in Review

Citadel Advisors sold out of ClearPoint Neuro (CLPT) in Q1 2026, closing a stake of 43,364 shares — an estimated $548K sold.

Citadel Advisors first reported a position in CLPT in Q3 2019 and held it in 19 quarters. The position peaked at $1.88M in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Citadel Advisors reported no remaining ClearPoint Neuro position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 43,364 ClearPoint Neuro shares in Q1 2026, an estimated $548K.
  • Citadel Advisors first reported a position in ClearPoint Neuro in Q3 2019 and held it in 19 quarters.
  • Citadel Advisors's ClearPoint Neuro position peaked at $1.88M in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.